Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Novacyt S.A. NCYT.L
$43.18
+$1.37 (3.17%)
На 18:02, 12 мая 2023
Ранг: 1
Ключевые показатели
-
Marketcap
30863649.00000000
-
week52high
179.95
-
week52low
1.32
-
Revenue
21040000
-
P/E TTM
0
-
Beta
-2.20190800
-
EPS
-0.04000000
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 04:33
Описание компании
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии